GCM
BLFS icon

Graham Capital Management’s BioLife Solutions BLFS Stock Holding History

Graham Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,716
Closed -$375K – 1242
2025
Q3 		$375K Sell
14,716
-9,231
-39% -$219K 0.01% 742
2025
Q2 		$516K Buy
+23,947
New +$540K 0.01% 804
2025
Q1 		– Sell
-9,781
Closed -$254K – 1301
2024
Q4 		$254K Buy
+9,781
New +$243K ﹤0.01% 992
2023
Q2 		– Sell
-11,204
Closed -$244K – 978
2023
Q1 		$244K Buy
+11,204
New +$252K 0.01% 923
2022
Q2 		– Sell
-19,537
Closed -$444K – 1016
2022
Q1 		$444K Buy
+19,537
New +$514K 0.02% 591

Other funds holding BLFS

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Graham Capital Management's BLFS Position: Q4 2025 in Review

Graham Capital Management sold out of BioLife Solutions (BLFS) in Q4 2025, closing a stake of 14,716 shares — an estimated $375K sold.

Graham Capital Management first reported a position in BLFS in Q1 2022 and held it in 5 quarters. The position peaked at $516K in Q2 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q4 2025.

  • Graham Capital Management reported no remaining BioLife Solutions position as of Q4 2025 after selling out during the quarter.
  • Graham Capital Management sold 14,716 BioLife Solutions shares in Q4 2025, an estimated $375K.
  • Graham Capital Management first reported a position in BioLife Solutions in Q1 2022 and held it in 5 quarters.
  • Graham Capital Management's BioLife Solutions position peaked at $516K in Q2 2025.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.